Brief: Abionyx Pharma H1 Operating Loss Narrows To 1.0 Million Euros

Abionyx Pharma SA

10/09/2020 17:46

Sept 10 (Reuters) - ABIONYX PHARMA SA  ABNX.PA :
    * CASH AND CASH EQUIVALENTS AMOUNTED TO EUR 8.81 MILLION AT
JUNE
30, 2020
    * H1 NET LOSS EUR 1.0 MILLION VERSUS PROFIT EUR 2.9 MILLION
YEAR
AGO
    * H1 OPERATING INCOME WENT FROM A LOSS OF EUR 1.446 MILLION
AT
JUNE 30, 2019 TO A LOSS OF EUR 1.041 MILLION AT JUNE 30, 2020
    * GIVEN CURRENT CONTEXT OF HEALTHCARE SYSTEMS IMPACTED BY
COVID-19, COMPANY IS STILL AWAITING CLINICAL DATA THAT MAY
IMPACT COMPLETION OF NEW STRATEGIC PLAN

Source text for Eikon:  ID:nBw3lV6Rca 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))